Thursday 16 March

8:45 – 9:05 AM - In-person registration. All delegates will be required to collect a name badge and security pass from the foyer of 1 Reserve Road, St Leonards

Session 1: Overview

Chair: Ellen Donnan - NSW TB Program, Health Protection NSW

• 9:15 Conference introduction TBC Health Protection NSW
• 9:20 Welcome to country TBC Metropolitan Local Aboriginal Lands Council
• 9:30 Conference Administration Ellen Donnan NSW TB Program, Health Protection NSW
• 9:35 Tuberculosis: Global Situation and challenges to End TB Scientia Professor Guy Marks AO TB Centre for Research Excellence, Woolcock Institute of Medical Research, The University of Sydney, South Western Sydney Local Health District
• 9:55 Australian overview and the National Strategic Plan Ellen Donnan NSW TB Program, Health Protection NSW, National TB Advisory Committee
• 10:15 New WHO child and adolescent TB guidelines and drug susceptible-TB treatment update Professor Ben Marais Sydney Children's Hospital Network, Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney
• 10:30 Morning Tea

Session 2: Migrant trends and work in the Region

Chair: Scientia Professor Guy Marks AO - TB Centre for Research Excellence, Woolcock Institute, University of Sydney, South Western Sydney Local Health District

• 11:00 Australian migration trends Dr Cheryl Ou Yong Department of Home Affairs
• 11:20 TB in migrants during and post COVID-19 Jennifer Pett NSW TB Program, Health Protection NSW
• 11:30 Evidence based approach to assess the risk of tuberculosis among visitors and migrants to Australia Dr Gabriella Scandurra The University of Sydney
• 11:45 PEARL study - key learnings (Virtual) Dr Mikaela Coleman The University of Sydney, Sydney Global Maternal and Child Health Network
• 12:00 Australia's response to tuberculosis in the Indo-Pacific Region Klara Henderson Department of Foreign Affairs and Trade
• 12:20 Outcome of a household contact tracing program and provision of tuberculosis preventive therapy in Dili, Timor Leste (Virtual) Misella Soares Maluk Timor
• 12:30 Lunch

Session 3: Incorporation whole genome sequencing into clinical and public health practice

Chair: Professor Ben Marais – Sydney Children's Hospital Network, Sydney Infectious Diseases (Sydney ID), The University of Sydney

• 13:30 Whole genome sequencing for clinical and public health Ellen Donnan NSW TB Program, Health Protection NSW
• 13:45 Impact of drug resistance conferring mutations in Mycobacterium tuberculosis on treatment outcomes   Professor Vitali Sintchenko Institute of Clinical Pathology and Medical Research – NSW Health Pathology, Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney
• 14:00 Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation (Virtual) Dr Michael Hall The Peter Doherty Institute, University of Melbourne
• 14:20 Insights into TB transmission within NSW from whole genome sequencing Catriona Furlong NSW TB Program, Health Protection NSW
• 14:40 Whole genome sequencing for tuberculosis in Victoria, Australia: a genomic implementation study from 2017-2020 (Virtual) Dr Katie Dale Victorian Tuberculosis Program
• 15:00 Afternoon tea

Session 4: TB transmission and clusters

Chair: Amanda Christensen AM – Australian Respiratory Council

• 15:30 Nosocomial transmission of tuberculosis to a surgeon following washout of a tuberculous septic arthritic elbow Dr Timothy Gray Concord Hospital, Sydney Local Health District
• 15:45 TB in childcare Sherri Towle Wollongong Hospital, Illawarra Shoalhaven Local Health District
• 16:00 TB outbreak in a boarding house detected via whole genome sequencing, Sydney, 2022 Eunice Stiboy South Eastern Sydney Local Health District Public Health Unit
• 16:15 Tracing TB in contacts and cluster in a hospital office Evan Ulbricht Parramatta Chest Clinic, Western Sydney Local Health District

Posters and canapes

16:30-18:30 Please join us to view the poster presentations and for canapes and refreshments

Friday 17 March

8:30 – 9:00 AM - In-person registration. All delegates will be required to collect a security pass from the foyer of 1 Reserve Road, St Leonards

Session 5: Clinical and therapeutics

Chair: Dr Jin-Gun Cho – Western Sydney Local Health District

• 9:00 Post TB mortality data linkage Associate Professor Anthony Byrne St Vincent's Hospital, St George Hospital South Eastern Sydney Local Health District
• 9:15 Pulmonary tuberculosis in an adolescent girl post SARS-CoV-2 infection Dr Abhinav Rajkumar (Virtual) Royal Prince Alfred Hospital, Sydney Local Health District
• 9:25 The impact of the COVID-19 pandemic on tuberculosis control in a low tuberculosis-burden setting Dr Toni Maldari South Australian TB Service
• 9:40 Factors leading to diagnostic delay of tuberculosis in the Top End of Australia (Virtual) Dr Nilanthy Vigneswaran Royal Darwin Hospital
• 9:55 Point-of-care saliva test for TDM of TB drugs. Are we there yet? Professor Jan-Willem Alffenaar The University of Sydney, Western Sydney Local Health District
• 10:15 Implementation of an asynchronous directly observed therapy TB treatment program – an Australian TB Service experience (Virtual) Hyejin Jeon South Australian TB Service
• 10:30 Morning tea

Session 6: Latent TB infection and cultural engagement

Chair: Flora van der Heide - Sydney Local Health District

• 11:00 Quiz time!
• 11:10 Models of care for latent TB screening and treatment in primary care: a scoping review (Virtual) Dr Madhumati Chatteri The University of Queensland
• 11:25 Project: Latent Tuberculosis Management in General Practice Ann-Marie Baker Victorian TB Program
• 11:40 Management of tuberculosis infection in Victorian children: A retrospective clinical audit of factors affecting treatment completion (Virtual) Dr Rebecca Holmes Barwon Health
• 11:50 TB stigma - consideration for TB and LTBI treatment Associate Professor Chris Degeling University of Wollongong
• 12:10 Local engagement strategies for Pasifika community in South Western Sydney Dr Stephen Conaty/Marie Reyes/Rania Matta South Western Sydney Local Health District
• 12:30 Lunch

Session 7: Multidrug resistant TB

Chair: Professor Greg Fox – Sydney Local Health District, The University of Sydney

• 13:30 WHO MDR-TB guidelines and development Dr Tasnim Hasan The University of Sydney, Western Sydney Local Health District
• 14:00 Linezolid adverse events in NSW MDR-TB patients diagnosed in 2019-2020 TBC TBC
• 14:15 Paediatric MDR-TBM case review Associate Professor Philip Britton Sydney Children's Hospital Network
• 14:25 Linezolid toxicity in an MDR-TB case Dr Soo Wei Foo Concord Repatriation General Hospital, Sydney Local Health District
• 14:35 Pulmonary MDR-TB, COVID-19 coinfection and reduced duration treatment regimen including BPaLM: A Case Report Dr Breman Janarthanan The Canberra Hospital Session 7 continued
• 14:45 Preliminary assessment of effectiveness and safety of 6 and 9 months All Oral Regimens in patients with rifampicin-resistant tuberculosis Dr Natalia Yatskevich Republican Research and Practical Centre of Pulmonology and Tuberculosis, Belarus
• 15:00 Afternoon tea

Session 8: Education and research

Chair: Associate Professor Claudia Dobler – South Western Sydney Local Health District, University of New South Wales, NSW TB Advisory Committee Chair

• 15:30 Patient Experience of Tuberculosis Diagnosis and Management: A Pilot Study (Virtual) Dr Kim Yeoh Victorian Tuberculosis Program, The Doherty Institute, The Royal Melbourne Hospital
• 15:45 The use of weekly rifapentine and isoniazid (3HP) for latent TB infection in Australia Dr Vicky Chang South Eastern Local Health District, The University of Sydney
• 16:00 Randomised Controlled Trial of Adjunctive Rosuvastatin for Tuberculosis Treatment Dr Gail Cross National University Health System, Singapore
• 16:15 TB Nursing Education Amanda Christensen AM Australian Respiratory Council
• 16:30 Close

Poster presentations

• Toddlers and TB testing taskforce Lily Dharmaraj - Gosford Chest Clinic, Central Coast Local Health District
• Updates to NSW BCG guidelines and resources Ellen Donnan - NSW TB Program, Health Protection NSW
• In vitro efficacy of new β-lactam - β-lactamase inhibitor combinations for Mycobacterium tuberculosis Lina Davies Forsman – The University of Sydney, Westmead Hospital, Karolinska Institutet
• A 10 year case review of TB cases in Murrumbidgee Local Health District Emma Hunt – Southern NSW/Murrumbidgee Local Health Districts Public Health Unit
  
• Complexities and compliance in a case of TB - communication and collaboration are key Amy Peachey – Victorian TB Program

Tuberculosis Conference 2023 Sponsorship

​